Introduction Pulmonary arterial hypertension (PAH) is a progressive and life-threatening disorder characterized by elevated pulmonary vascular resistance (PVR), leading to right ventricular failure and early mortality (1). Despite the availability of therapies, many patients remain symptomatic, underlining the need for novel treatments that target
426 Reached
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Woman presented with Fever of Unknown Origin
7713 Reached93 Comments19 Likes
How Physicians Should Manage Stress?
35294 Reached152 Comments203 Likes
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Pregnant Woman with HIV-1 Infection
747 Reached1 Likes